News

Mast Group Ltd. exhibited at the Institute of Biomedical Science Congress 2019 at the International Convention Centre in Birmingham 22^nd – 25^th September 2019, and it proved to be a triumph!

Public Health England have recently reported a 20% increase in Syphilis diagnoses

MAST^®STREP Rapid latex slide agglutination test for Identification of Streptococci of Lancefield Groups A, B, C, D, F and G.

Staphylococcus aureus is a Gram-positive coccus, that is a member of the Firmicutes and is a commonly found member of the microbiota of the body.

Mast Group Ltd has been a manufacturer of antibiotic susceptibility test (AST) products since 1957 and continues to be at the forefront of developments in this field. 

Since the launch of new additions to the MASTDISCS^® range – Meropenem-Vaborbactam 20-10µg (MEV30C), Eravacycline 20µg (ERV20C) and Delafloxacin 5µg (DLX5C) at ECCMID 2019, we have had a positive response to these novel compounds for the treatment of complicated infections.

Mast Group Ltd. has been manufacturing AST discs for over 60 years, with a history of experience, quality and innovation, the expansion of the portfolio has resulted in the most comprehensive range available world-wide.